Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australian Labor Government Slashes Drug Prices For Big Pharma, Delivers Tax Credits To Struggling Biotech In 2009 Budget

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - The Australian federal 2009-2010 budget announced May 12, delivered a mixed bag to pharmaceutical and biotech companies, with biotech companies praising the R&D tax credit and Big Pharma critical of cuts to the Pharmaceutical Benefits Scheme

You may also be interested in...

Medicines Australia Says Pharmaceutical Benefits Scheme Spending Sustainable

PERTH, Australia - A new report by Access Economics says that spending on Australia's Pharmaceutical Benefits Scheme will not spiral out of control as previously predicted by the Liberal Howard government, Medicines Australia announced April 3

Australia Department Of Innovation Releases 10-Year Plan On Pharma Strategy

PERTH, Australia - Australia's Minister for Innovation, Industry, Science and Research, Senator Kim Carr, has released a sweeping report that outlines a 10-year plan for the country's pharmaceutical and biotech industry

Australian Biotech Faces Perfect Storm

PERTH, Australia - Investment in Australia's biotech sector plummeted to AU$183 million in 2008, down from AU$ 943 million in 2007, AusBiotech reported

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts